AAP
ZYME icon

Arax Advisory Partners’s Zymeworks ZYME Stock Holding History

Arax Advisory Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-169
Closed -$4.45K – 4395
2025
Q4 		$4.45K Sell
169
-2,812
-94% -$61.3K ﹤0.01% 2923
2025
Q3 		$50.9K Buy
+2,981
New +$42.7K ﹤0.01% 1828
2025
Q1 		– Sell
-169
Closed -$2.48K – 3089
2024
Q4 		$2.48K Sell
169
-47
-22% -$657 ﹤0.01% 1959
2024
Q3 		$2.71K Hold
216
– – ﹤0.01% 1947
2024
Q2 		$1.84K Buy
+216
New +$1.92K ﹤0.01% 1995

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arax Advisory Partners's ZYME Position: Q1 2026 in Review

Arax Advisory Partners sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 169 shares — an estimated $4.45K sold.

Arax Advisory Partners first reported a position in ZYME in Q2 2024 and held it in 5 quarters. The position peaked at $50.9K in Q3 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Arax Advisory Partners reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 169 Zymeworks shares in Q1 2026, an estimated $4.45K.
  • Arax Advisory Partners first reported a position in Zymeworks in Q2 2024 and held it in 5 quarters.
  • Arax Advisory Partners's Zymeworks position peaked at $50.9K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.